Seres Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Seres Therapeutics granted stock options to purchase 4,200 shares to two new employees on September 4, 2026, with an exercise price of $5.72 per share under its 2022 Employment Inducement Award Plan. The options vest 25% on the first anniversary and 6.25% quarterly thereafter.